Cargando…
Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349555/ https://www.ncbi.nlm.nih.gov/pubmed/35702878 http://dx.doi.org/10.1002/ajh.26626 |
| _version_ | 1784762130441961472 |
|---|---|
| author | Blennow, Ola Salmanton‐García, Jon Nowak, Piotr Itri, Federico Van Doesum, Jaap López‐García, Alberto Farina, Francesca Jaksic, Ozren Pinczés, László Imre Bilgin, Yavuz M. Falces‐Romero, Iker Jiménez, Moraima Ormazabal‐Vélez, Irati Weinbergerová, Barbora Duléry, Rémy Stojanoski, Zlate Lahmer, Tobias Fernández, Noemí Hernández‐Rivas, José‐Ángel Petzer, Verena De Jonge, Nick Glenthøj, Andreas De Ramón, Cristina Biernat, Monika M. Fracchiolla, Nicola Aujayeb, Avinash Van Praet, Jens Schönlein, Martin Méndez, Gustavo‐Adolfo Cattaneo, Chiara Guidetti, Anna Sciumè, Mariarita Ammatuna, Emanuele Cordoba, Raul García‐Poutón, Nicole Gräfe, Stefanie Cabirta, Alba Wolf, Dominik Nordlander, Anna García‐Sanz, Ramón Delia, Mario Berg Venemyr, Caroline Brones, Clara Di Blasi, Roberta De Kort, Elizabeth Meers, Stef Lamure, Sylvain Serrano, Laura Merelli, Maria Coppola, Nicola Bergantim, Rui Besson, Caroline Kohn, Milena Petiti, Jessica Garcia‐Vidal, Carolina Dargenio, Michelina Danion, François Machado, Marina Bailén‐Almorox, Rebeca Hoenigl, Martin Dragonetti, Giulia Chai, Louis Yi Ann Kho, Chi Shan Bonanni, Matteo Liévin, Raphaël Marchesi, Francesco Cornely, Oliver A. Pagano, Livio |
| author_facet | Blennow, Ola Salmanton‐García, Jon Nowak, Piotr Itri, Federico Van Doesum, Jaap López‐García, Alberto Farina, Francesca Jaksic, Ozren Pinczés, László Imre Bilgin, Yavuz M. Falces‐Romero, Iker Jiménez, Moraima Ormazabal‐Vélez, Irati Weinbergerová, Barbora Duléry, Rémy Stojanoski, Zlate Lahmer, Tobias Fernández, Noemí Hernández‐Rivas, José‐Ángel Petzer, Verena De Jonge, Nick Glenthøj, Andreas De Ramón, Cristina Biernat, Monika M. Fracchiolla, Nicola Aujayeb, Avinash Van Praet, Jens Schönlein, Martin Méndez, Gustavo‐Adolfo Cattaneo, Chiara Guidetti, Anna Sciumè, Mariarita Ammatuna, Emanuele Cordoba, Raul García‐Poutón, Nicole Gräfe, Stefanie Cabirta, Alba Wolf, Dominik Nordlander, Anna García‐Sanz, Ramón Delia, Mario Berg Venemyr, Caroline Brones, Clara Di Blasi, Roberta De Kort, Elizabeth Meers, Stef Lamure, Sylvain Serrano, Laura Merelli, Maria Coppola, Nicola Bergantim, Rui Besson, Caroline Kohn, Milena Petiti, Jessica Garcia‐Vidal, Carolina Dargenio, Michelina Danion, François Machado, Marina Bailén‐Almorox, Rebeca Hoenigl, Martin Dragonetti, Giulia Chai, Louis Yi Ann Kho, Chi Shan Bonanni, Matteo Liévin, Raphaël Marchesi, Francesco Cornely, Oliver A. Pagano, Livio |
| author_sort | Blennow, Ola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9349555 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93495552022-08-04 Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report Blennow, Ola Salmanton‐García, Jon Nowak, Piotr Itri, Federico Van Doesum, Jaap López‐García, Alberto Farina, Francesca Jaksic, Ozren Pinczés, László Imre Bilgin, Yavuz M. Falces‐Romero, Iker Jiménez, Moraima Ormazabal‐Vélez, Irati Weinbergerová, Barbora Duléry, Rémy Stojanoski, Zlate Lahmer, Tobias Fernández, Noemí Hernández‐Rivas, José‐Ángel Petzer, Verena De Jonge, Nick Glenthøj, Andreas De Ramón, Cristina Biernat, Monika M. Fracchiolla, Nicola Aujayeb, Avinash Van Praet, Jens Schönlein, Martin Méndez, Gustavo‐Adolfo Cattaneo, Chiara Guidetti, Anna Sciumè, Mariarita Ammatuna, Emanuele Cordoba, Raul García‐Poutón, Nicole Gräfe, Stefanie Cabirta, Alba Wolf, Dominik Nordlander, Anna García‐Sanz, Ramón Delia, Mario Berg Venemyr, Caroline Brones, Clara Di Blasi, Roberta De Kort, Elizabeth Meers, Stef Lamure, Sylvain Serrano, Laura Merelli, Maria Coppola, Nicola Bergantim, Rui Besson, Caroline Kohn, Milena Petiti, Jessica Garcia‐Vidal, Carolina Dargenio, Michelina Danion, François Machado, Marina Bailén‐Almorox, Rebeca Hoenigl, Martin Dragonetti, Giulia Chai, Louis Yi Ann Kho, Chi Shan Bonanni, Matteo Liévin, Raphaël Marchesi, Francesco Cornely, Oliver A. Pagano, Livio Am J Hematol Correspondences John Wiley & Sons, Inc. 2022-06-28 2022-08 /pmc/articles/PMC9349555/ /pubmed/35702878 http://dx.doi.org/10.1002/ajh.26626 Text en © 2022 The Authors. American Journal of Hematology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Correspondences Blennow, Ola Salmanton‐García, Jon Nowak, Piotr Itri, Federico Van Doesum, Jaap López‐García, Alberto Farina, Francesca Jaksic, Ozren Pinczés, László Imre Bilgin, Yavuz M. Falces‐Romero, Iker Jiménez, Moraima Ormazabal‐Vélez, Irati Weinbergerová, Barbora Duléry, Rémy Stojanoski, Zlate Lahmer, Tobias Fernández, Noemí Hernández‐Rivas, José‐Ángel Petzer, Verena De Jonge, Nick Glenthøj, Andreas De Ramón, Cristina Biernat, Monika M. Fracchiolla, Nicola Aujayeb, Avinash Van Praet, Jens Schönlein, Martin Méndez, Gustavo‐Adolfo Cattaneo, Chiara Guidetti, Anna Sciumè, Mariarita Ammatuna, Emanuele Cordoba, Raul García‐Poutón, Nicole Gräfe, Stefanie Cabirta, Alba Wolf, Dominik Nordlander, Anna García‐Sanz, Ramón Delia, Mario Berg Venemyr, Caroline Brones, Clara Di Blasi, Roberta De Kort, Elizabeth Meers, Stef Lamure, Sylvain Serrano, Laura Merelli, Maria Coppola, Nicola Bergantim, Rui Besson, Caroline Kohn, Milena Petiti, Jessica Garcia‐Vidal, Carolina Dargenio, Michelina Danion, François Machado, Marina Bailén‐Almorox, Rebeca Hoenigl, Martin Dragonetti, Giulia Chai, Louis Yi Ann Kho, Chi Shan Bonanni, Matteo Liévin, Raphaël Marchesi, Francesco Cornely, Oliver A. Pagano, Livio Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title | Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title_full | Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title_fullStr | Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title_full_unstemmed | Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title_short | Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report |
| title_sort | outcome of infection with omicron sars‐cov‐2 variant in patients with hematological malignancies: an epicovideha survey report |
| topic | Correspondences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349555/ https://www.ncbi.nlm.nih.gov/pubmed/35702878 http://dx.doi.org/10.1002/ajh.26626 |
| work_keys_str_mv | AT blennowola outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT salmantongarciajon outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT nowakpiotr outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT itrifederico outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT vandoesumjaap outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT lopezgarciaalberto outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT farinafrancesca outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT jaksicozren outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT pinczeslaszloimre outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bilginyavuzm outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT falcesromeroiker outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT jimenezmoraima outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT ormazabalvelezirati outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT weinbergerovabarbora outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT duleryremy outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT stojanoskizlate outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT lahmertobias outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT fernandeznoemi outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT hernandezrivasjoseangel outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT petzerverena outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT dejongenick outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT glenthøjandreas outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT deramoncristina outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT biernatmonikam outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT fracchiollanicola outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT aujayebavinash outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT vanpraetjens outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT schonleinmartin outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT mendezgustavoadolfo outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT cattaneochiara outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT guidettianna outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT sciumemariarita outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT ammatunaemanuele outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT cordobaraul outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT garciapoutonnicole outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT grafestefanie outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT cabirtaalba outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT wolfdominik outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT nordlanderanna outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT garciasanzramon outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT deliamario outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bergvenemyrcaroline outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bronesclara outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT diblasiroberta outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT dekortelizabeth outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT meersstef outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT lamuresylvain outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT serranolaura outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT merellimaria outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT coppolanicola outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bergantimrui outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bessoncaroline outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT kohnmilena outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT petitijessica outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT garciavidalcarolina outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT dargeniomichelina outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT danionfrancois outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT machadomarina outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bailenalmoroxrebeca outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT hoeniglmartin outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT dragonettigiulia outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT chailouisyiann outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT khochishan outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT bonannimatteo outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT lievinraphael outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT marchesifrancesco outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT cornelyolivera outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport AT paganolivio outcomeofinfectionwithomicronsarscov2variantinpatientswithhematologicalmalignanciesanepicovidehasurveyreport |